Join our webinar, “LFS and Chemo Prevention,” on Monday, June 2, 2014 from 7-9pm (EST)! The webinar is presented by Farzana Walcott, MD. Dr. Walcott is currently the Lead Associate Investigator for the chemoprevention study in Li-Fraumeni Syndrome using Metformin at the National Cancer Institute. Dr. Walcott received her M.P.H. at the University of Texas Health Science Center at the Houston School of Public Health in epidemiology, and her M.D. at the Texas A&M Health Science Center College of Medicine in College Station. She shares her interests in gynecologic malignancies, telomere biology, and chemoprevention with her projects related to the Li-Fraumeni Syndrome.
